Table 2.
Sensitivity and specificity among subgroups depending on the chosen point.
| Cut-off point for 100% specificity for MT | Equilibrium point between sensibility and specificity | |
|---|---|---|
| Entire population | 35 mg/L | 10 mg/L |
| Sensitivity | 54.2% | 66.7% |
| Specificity | 100% | 53.6% |
| Gender: male | 35 mg/L | 10 mg/L |
| Sensitivity | 60% | 100% |
| Specificity | 100% | 52.4% |
| BP ≥ 130/80 mmHg | 35 mg/L | 10 mg/L |
| Sensitivity | 52.4% | 66.7% |
| Specificity | 100% | 53.6% |
| CHT/C-HDL ratio ≥ 3 | 35 mg/L | 10 mg/L |
| Sensitivity | 58.3% | 58.3% |
| Specificity | 100% | 57.5% |
| T2D duration >5 years | 35 mg/L | 10 mg/L |
| Sensitivity | 66.7% | 75% |
| Specificity | 100% | 60% |